Program Description: 

We discuss and present new patients diagnosed with hematologic malignancies, their underlying biology and risk stratification, treatment plan, predicted results in addition to those patients with relapse/refractory disease. We discuss new therapies, clinical trials, diagnostic dilemmas. We review biology, molecular and cytogenic findings, flow cytometry and morphology.

Target audience: 
  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Fellows
Learning objectives: 
Participants who engage in this educational intervention will be able to:
  • Assess patients with hematologic malignancies by integrating disease biology and risk stratification to inform individualized treatment plans and estimate clinical outcomes.
  • Evaluate emerging therapies and clinical trial options to inform treatment decisions for patients with hematologic malignancies.
  • Interpret molecular, cytogenetic, flow cytometric, and morphologic findings in the context of disease biology to resolve diagnostic challenges in hematologic malignancies.

Tips for writing good learning objectives

Faculty & credentials: 
Activity Director(s):
Michael Burke, MD
Professor, Pediatric Hematology & Oncology, MCW
Leukemia/Lymphoma Director, MACC Fund Center

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose.

  • List individuals WITHOUT conflict here 

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

NameCompanyRole
   
   

DELETE THIS NOTE BEFORE PUBLISHING! REFER TO PAGE 7 & 8 OF THE BEST PRACTICES IN ETHOSCE ACTIVITY CREATION TO ENSURE INFORMATION IN THIS SECTION IS LISTED CORRECTLY.

Contact

Name: 
Alicia Copp

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.

MOC Part II:

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Participation shared with ABP through PARS:

Individual participants’ information will be shared with ABP through the ACCME Program and Activity Reporting System (PARS).

Session date: 
01/01/2027 - 8:39am CST
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Please login or register to take this course.